Innovation of novel ‘Tab in Tab’ system for release modulation of milnacipran HCl: optimization, formulation and in vitro investigations

References

• Prescott LF, Nimmo WS. (1989). Novel Drug Delivery and Its Therapeutic Application. New York: John Wiley and Sons.
   Google Scholar
• Mishra M, Mishra B. (2010). Design and evaluation of microporous membrane coated matrix tablets for a highly water soluble drug. Chem Pharm Bull, 58:995–1000.
   PubMed Web of Science ®Google Scholar
• Al-Saidan SM, Krishnaiah YS, Satyanarayana V, Bhaskar P, Karthikeyan RS. (2004). Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug. Eur J Pharm Biopharm, 58:697–703.
   PubMed Web of Science ®Google Scholar
• Abd El-Halim SM, Amin MM, El-Gazayerly ON, Abd El-Gawad NA. (2010). Comparative study on the different techniques for the preparation of sustained release hydrophobic matrices of a highly water-soluble drug. Drug Discover Thera, 4(6):484–492.
   PubMedGoogle Scholar
• Kotwal PM, Howard SA. (2006). Multilayered Controlled Release Pharmaceutical Dosage Form. In: US PTO, ed. Raritan, NJ: Ortho Pharmaceutical corporation.
   Google Scholar
• Chen X, Wen H, Park K. (2010). Challenges and new technologies of oral controlled release. In: Wen H, Park K, eds. Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. New Jersey: John Wiley and Sons, 257–277.
   Google Scholar
• Lopes CM, Lobo JM, Pinto JF, Costa PC. (2007). Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPS PharmSciTech, 8:E76.
   PubMedGoogle Scholar
• Kenneth CH, Leung AK. (1987). Hypospadias: a review. J Singapore Paediatr Soc, 29:54–56.
   PubMedGoogle Scholar
• Puozzo C, Leonard BE. (1996). Pharmacokinetics of milnacipran in comparison with other antidepressants. Int Clin Psychopharmacol, 11 Suppl 4:15–27.
   PubMed Web of Science ®Google Scholar
• Ansseau M, Papart P, Troisfontaines B, Bartholomé F, Bataille M, Charles G et al. (1994). Controlled comparison of milnacipran and fluoxetine in major depression. Psychopharmacology (Berl), 114:131–137.
   PubMed Web of Science ®Google Scholar
• Faham A, Prinderre P, Farah N, Eichler KD, Kalantzis G, Joachim J. (2000). Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release. Drug Dev Ind Pharm, 26:167–176.
   PubMed Web of Science ®Google Scholar
• Sutananta W, Craig DQ, Newton JM. (1995). An evaluation of the mechanisms of drug release from glyceride bases. J Pharm Pharmacol, 47:182–187.
   PubMed Web of Science ®Google Scholar
• Mirghani A, Idkaidek NM, Salem MS, Najib NM. (2000). Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate. Drug Dev Ind Pharm, 26:791–795.
   PubMed Web of Science ®Google Scholar
• Gohel MC, Parikh RK, Nagori SA, Jena DG. (2009). Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum. AAPS PharmSciTech, 10:62–68.
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Rajabi-Siahboomi AR. (2008). Extended-release oral drug delivery technologies: monolithic matrix systems. In: Jain KK, ed. Drug Delivery Systems. Totowa, NJ: Humana Press, 217–243.
   Google Scholar
• Rajabi-Siahboomi AR, Jordan MP. (2000). Slow release HPMC matrix systems. Eur Pharm Rev, 5:21–23.
   Google Scholar
• Mohamed FA, Roberts M, Seton L, Ford JL, Levina M, Rajabi-Siahboomi AR. (2012). The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets. Drug Dev Ind Pharm. Available at: http://informahealthcare.com/loi/ddi/doi/10.3109/03639045.2012.681053. Accessed on 1 September 2012.
   Web of Science ®Google Scholar
• Gohel M, Nagori SA. (2009). Fabrication and evaluation of captopril modified-release oral formulation. Pharm Dev Technol, 14:679–686.
   PubMed Web of Science ®Google Scholar
• Parejiya PB, Barot BS, Shelat PK, Patel RC, Shukla AK. (2011). Development and validation of analytical methods of milnacipran hydrochloride in bulk and pharmaceutical formulations. Eurasian J Anal Chem, 6(1):67–75.
   Google Scholar
• Patel GM, Patel MM. (2009). Compressed matrix dual-component vaginal drug delivery system containing metoclopramide hydrochloride. Acta Pharm, 59:273–288.
   PubMed Web of Science ®Google Scholar
• Subramanian N, Yajnik A, Murthy RS. (2004). Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes. AAPS PharmSciTech, 5:E4.
   PubMedGoogle Scholar
• IndianPharmacopoeia. (2010). General Monographs. 6th ed.. New Delhi: Government of India.
   Google Scholar
• Tongwen X, Binglin H. (1998). Mechanism of sustained drug release in diffusion-controlled polymer matrix-application of percolation theory. Int J Pharm, 170(2):139–149.
   Google Scholar
• Li FQ, Hu JH, Deng JX, Su H, Xu S, Liu JY. (2006). In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm, 324:152–157.
   PubMed Web of Science ®Google Scholar
• Zhang YE, Schwartz JB. (2003). Melt granulation and heat treatment for wax matrix-controlled drug release. Drug Dev Ind Pharm, 29:131–138.
   PubMed Web of Science ®Google Scholar
• Hamdani J, Moës AJ, Amighi K. (2003). Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm, 260:47–57.
   PubMed Web of Science ®Google Scholar
• Ozyazici M, Gökçe EH, Ertan G. (2006). Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm, 63:331–339.
   PubMed Web of Science ®Google Scholar
• Levison KK, Takayama K, Isowa K, Okabe K, Nagai T. (1994). Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers. J Pharm Sci, 83:1367–1372.
   PubMed Web of Science ®Google Scholar
• Shirakura O, Yamada M, Hashimoto M, Ishimaru S, Takayama K, Nagai T. (1991). Particle size design using computer optimization technique. Drug Dev Ind Pharm, 17(4):471–483.
   Web of Science ®Google Scholar
• Takayama K, Morva A, Fujikawa M, Hattori Y, Obata Y, Nagai T. (2000). Formula optimization of theophylline controlled-release tablet based on artificial neural networks. J Control Release, 68:175–186.
   PubMed Web of Science ®Google Scholar
• Takahara J, Takayama K, Nagai T. (1997). Multi objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J Control Release, 49(1):11–20.
   Web of Science ®Google Scholar
• Traynor MJ, Brown MB, Pannala A, Beck P, Martin GP. (2008). Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments. Drug Dev Ind Pharm, 34:885–889.
   PubMed Web of Science ®Google Scholar
• Parejiya PB, Barot BS, Patel HK, Shelat PK, Shukla AK. (2012). Development of platform technology for oral controlled delivery of highly water soluble drugs using milnacipran HCl as a model drug. Drug Deliv Lett, 2(1):35–45.
   Google Scholar
• Silverstein RM, Webster FX, Kiemle DJ. (2005). Spectrometric Identification of Organic Compounds. 7th ed. New York: John Wiley and Sons.
   Google Scholar
• Dani VR. (1995). Organic spectroscopy. 1st ed. New Delhi: Tata McGraw-Hill Publishing Company Ltd.
   Google Scholar
• Raj A, Raju K, Varghese HT, Granadeiro CM, Nogueira HIS, Panicker CY. (2009). IR, Raman and SERS spectra of 2-(methoxycarbonylmethylsulfanyl)-3,5-dinitrobenzene carboxylic acid. J Braz Chem Soc, 20(3):549–559.
   Web of Science ®Google Scholar
• Govindarajan M, Periandy S, Ganesan K. (2010). Scaled quantum FT-IR and FT-Raman spectral analysis of 1-methoxynaphthalene. E-Journal of Chemistry, 7(2):457–464.
   Web of Science ®Google Scholar
• Ibrahim M, Alaam M, El-Haes H, Jalbout AF, Leon A. (2006). Analysis of the structure and vibrational spectra of glucose and fructose. Eclética Química, 31:15–21.
   Google Scholar
• Brubach JB, Jannin V, Mahler B, Bourgaux C, Lessieur P, Roy P et al. (2007). Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy. Int J Pharm, 336:248–256.
   PubMed Web of Science ®Google Scholar